Klinické štúdie CHOPN v štáte Louisiana
9 štúdií pre CHOPN hľadá účastníkov v zariadeniach v štáte Louisiana.
Mestá v štáte Louisiana
Oficiálny text štúdie (anglicky)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Lafayette
- Research Site, Monroe
- Research Site, Shreveport
- a 1 ďalších
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Ochsner LSU Health Shreveport - Academic Medical Center- Site Number : 8400083, Shreveport
- Care Access - Shreveport - Youree Drive- Site Number : 8400007, Shreveport
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Southern Clinical Research - Zachary- Site Number : 8400113, Zachary
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07190209A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
- GSK Investigational Site, Lake Charles
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07780669A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Zachary
Prebieha náborFáza 2
Vek 40 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07082738A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Southern Clinical Research, LLC, Zachary
Prebieha náborFáza 2/3
Vek 35 až 80 · Všetky pohlavia · Aktualizované 31. 8. 2026 · NCT07363694STRIVE Post-Market Registry Study
- LSU Health Shreveport, Shreveport
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Lake Charles
- GSK Investigational Site, Shreveport
Prebieha náborFáza 3
Vek 40 až 75 · Všetky pohlavia · Aktualizované 28. 7. 2026 · NCT07177339Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Baton Rouge
- GSK Investigational Site, Lafayette
- GSK Investigational Site, Shreveport
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 9. 4. 2026 · NCT06961214Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.